FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription

Cell Death and Differentiation

Volumn 19, Issue 4, 2012, Pages 616-622

  Dong, L ^a,b   Li, Y ^a   Cao, J ^a   Liu, F ^a   Pier, E ^a,f   Chen, J ^a   Xu, Z ^c   Chen, C ^d   Wang, R A ^e   Cui, R ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHANDONG UNIVERSITY   (China)

^c and Clinical Center   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^f TUFTS MEDICAL CENTER   (United States)

Author keywords

melanocyte; PAX3; pigment; UV

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MELANIN; MONOPHENOL MONOOXYGENASE; STAT3 PROTEIN; TRANSCRIPTION FACTOR PAX3;

ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL VIABILITY; EPIDERMIS; HYPERPIGMENTATION; KERATINOCYTE; MELANOCYTE; MELANOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN COLOR; TISSUE SPECIFICITY; ULTRAVIOLET B RADIATION; UPREGULATION;

ANIMALS; CELL SURVIVAL; FIBROBLAST GROWTH FACTOR 2; HUMANS; MELANOCYTES; MICE; MICE, TRANSGENIC; PAIRED BOX TRANSCRIPTION FACTORS; SIGNAL TRANSDUCTION; SKIN PIGMENTATION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

ANIMALIA; MUS MUSCULUS;

EID: 84858155299     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2011.132     Document Type: Article

References (38)

1. Halaban R. The regulation of normal melanocyte proliferation. Pigment Cell Res 2000; 13: 4-14. (Pubitemid 30184066)
2. Bromberg J, Darnell Jr JE. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000; 19: 2468-2473. (Pubitemid 30339202)
3. Kano A, Wolfgang MJ, Gao Q, Jacoby J, Chai GX, HansenWet al. Endothelial cells require STAT3 for protection against endotoxin-induced inflammation. J Exp Med 2003; 198: 1517-1525. (Pubitemid 37467166)
4. Pingault V, Ente D, Dastot-Le Moal F, Goossens M, Marlin S, Bondurand N. Review and update of mutations causing Waardenburg syndrome. Hum Mutat 2010; 31: 391-406.
5. Epstein DJ, Vogan KJ, Trasler DG, Gros P. A mutation within intron 3 of the Pax-3 gene produces aberrantly spliced mRNA transcripts in the splotch (Sp) mouse mutant. Proc Natl Acad Sci USA 1993; 90: 532-536. (Pubitemid 23028897)
6. Brenner M, Degitz K, Besch R, Berking C. Differential expression of melanoma-associated growth factors in keratinocytes and fibroblasts by ultraviolet A and ultraviolet B radiation. Br J Dermatol 2005; 153: 733-739. (Pubitemid 41415898)
7. Imokawa G, Yada Y, Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 1992; 267: 24675-24680.
8. Berking C, Takemoto R, Satyamoorthy K, Elenitsas R, Herlyn M. Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin. Am J Pathol 2001; 158: 943-953. (Pubitemid 32221786)
9. Bansal R, Magge S, Winkler S. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells. J Neurosci Res 2003; 74: 486-493. (Pubitemid 37352070)
10. Lin JY, Fisher DE. Melanocyte biology and skin pigmentation. Nature 2007; 445: 843-850.
11. Goding CR. Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev 2000; 14: 1712-1728. (Pubitemid 30602990)
12. Yang X, Qiao D, Meyer K, Friedl A. Signal transducers and activators of transcription mediate fibroblast growth factor-induced vascular endothelial morphogenesis. Cancer Res 2009; 69: 1668-1677.
13. Bondurand N, Pingault V, Goerich DE, Lemort N, Sock E, Le Caignec C et al. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet 2000; 9: 1907-1917. (Pubitemid 30642654)
14. Lang D, Epstein JA. Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. Hum Mol Genet 2003; 12: 937-945. (Pubitemid 36504036)
15. Potterf SB, Furumura M, Dunn KJ, Arnheiter H, Pavan WJ. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum Genet 2000; 107: 1-6. (Pubitemid 30598938)
16. Yang G, Li Y, Nishimura EK, Xin H, Zhou A, Guo Y et al. Inhibition of PAX3 by TGF-beta modulates melanocyte viability. Mol Cell 2008; 32: 554-563.
17. Balmanno K, Cook SJ. Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ 2009; 16: 368-377.
18. Chung J, Uchida E, Grammer TC, Blenis J. STAT3 serine phosphorylation by ERKdependent and-independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 1997; 17: 6508-6516. (Pubitemid 27451197)
19. Schust J SB, Hollis A, Mayer TU, Berg T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 2006; 13: 1235-1242. (Pubitemid 44750735)
20. Lin L, Hutzen B, Zuo M, Ball S, Deangelis S, Foust E et al. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells. Cancer Res 2010; 70: 2445-2454.
21. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009; 9: 798-809.
22. Sano S, Chan KS, DiGiovanni J. Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci 2008; 50: 1-14. (Pubitemid 351249893)
23. Darnell Jr JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415-1421. (Pubitemid 24217131)
24. Seidel HM, Milocco LH, Lamb P, Darnell Jr JE, Stein RB, Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 1995; 92: 3041-3045.
25. Orchard GE, Calonje E. The effect of melanin bleaching on immunohistochemical staining in heavily pigmented melanocytic neoplasms. Am J Dermatopathol 1998; 20: 357-361. (Pubitemid 28363617)
26. Burns T, Breathnach S, Cox N, Griffiths C (eds). The Melanocyte. Rook's Textbook Dermatol, vol. 8. Blackwell Publishing: Oxford, UK, 2010, pp 58-60.
27. Harris RG, White E, Phillips ES, Lillycrop KA. The expression of the developmentally regulated proto-oncogene Pax-3 is modulated by N-Myc. J Biol Chem 2002; 277: 34815-34825.
28. Pruitt SC, Bussman A, Maslov AY, Natoli TA, Heinaman R. Hox/Pbx and Brn binding sites mediate Pax3 expression in vitro and in vivo. Gene Expr Patterns 2004; 4: 671-685. (Pubitemid 39307530)
29. Smit DJ, Smith AG, Parsons PG, Muscat GE, Sturm RA. Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors. Eur J Biochem 2000; 267: 6413-6422.
30. Milewski RC, Chi NC, Li J, Brown C, Lu MM, Epstein JA. Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3. Development 2004; 131: 829-837. (Pubitemid 38263198)
31. Xie TX, Huang FJ, Aldape KD, Kang SH, Liu M, Gershenwald JE et al. Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res 2006; 66: 3188-3196.
32. Deo DD, Axelrad TW, Robert EG, Marcheselli V, Bazan NG, Hunt JD. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. J Biol Chem 2002; 277: 21237-21245. (Pubitemid 34952260)
33. Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D, Basilico C. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 1999; 13: 1361-1366. (Pubitemid 29270242)
34. Horikawa T, Norris DA, Zekman T, Morelli JG. Effective elimination of fibroblasts in cultures of melanocytes by lowering calcium concentration in TPA depleted medium following geneticin treatment. Pigment Cell Res 1996; 9: 58-62. (Pubitemid 126478568)
35. Dunham WR, Klein SB, Rhodes LM, Marcelo CL. Oleic acid and linoleic acid are the major determinants of changes in keratinocyte plasma membrane viscosity. J Invest Dermatol 1996; 107: 332-335. (Pubitemid 26284339)
36. Dong L WJ, Zhang X, Zhang B, Dong F, Ziegler N, Mysz M et al. Melanocytes-stimulating Hormone, a potential activator of XPA DNA repair. Cancer Res 2010; 70: 3547-3556.
37. Watts KP, Fairchild RG, Slatkin DN, Greenberg D, Packer S, Atkins HL et al. Melanin content of hamster tissues, human tissues, and various melanomas. Cancer Res 1981; 41: 467-472. (Pubitemid 11179382)
38. Das KC, Abramson MB, Katzman R. Neuronal pigments: spectroscopic characterization of human brain melanin. J Neurochem 1978; 30: 601-605. (Pubitemid 8291437)